CML-417: ASCEMBL Phase 3 Health-Related Quality of Life (HRQL) Comparison of Asciminib and Bosutinib for Patients with Chronic Myelogenous Leukemia in Chronic Phase (CML-CP), Previously Treated with 2 or More Tyrosine Kinase Inhibitors (TKI)

2021 ◽  
Vol 21 ◽  
pp. S336
Author(s):  
Michael J. Mauro ◽  
Carla Boquimpani ◽  
Delphine Réa ◽  
Andreas Hochhaus ◽  
Vikalp Kumar Maheshwari ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Kinase Inhibitors ◽  
Chronic Phase ◽  
Myelogenous Leukemia ◽  
Health Related Quality ◽  
Phase 3 ◽  
Related Quality ◽  
Health Related ◽  
Previously Treated

scholarly journals Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies

2018 ◽  
Vol 13 (1) ◽  
pp. 139-140 ◽  
Author(s):  
Julian Panés ◽  
Séverine Vermeire ◽  
James O Lindsay ◽  
Bruce E Sands ◽  
Chinyu Su ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Ulcerative Colitis ◽  
Health Related Quality ◽  
Phase 3 ◽  
Related Quality ◽  
Health Related ◽  
Randomised Controlled
Sign in / Sign up

Export Citation Format

Share Document